Stay updated with breaking news from Notable Labs. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Notable Labs (NASDAQ:NTBL – Free Report) had its target price decreased by Chardan Capital from $7.00 to $5.00 in a research report report published on Thursday morning, Benzinga reports. Chardan Capital currently has a buy rating on the stock. Separately, JMP Securities reiterated a market outperform rating and set a $9.00 target price on shares […]
JMP Securities reaffirmed their market outperform rating on shares of Notable Labs (NASDAQ:NTBL – Free Report) in a research note issued to investors on Monday morning, Benzinga reports. They currently have a $9.00 price objective on the stock. Separately, Chardan Capital lowered their price objective on Notable Labs from $9.00 to $7.00 and set a […]
Notable Labs (NASDAQ: ) just reported results for the fourth quarter of 2023. InvestorPlace Earnings is a project that leverages data from TradeSmith to…
Poster outlines the parameters for developing a flow-cytometry-based PPMP as a companion diagnostic to predict volasertib responders, based on a...
Notable Labs, Ltd. (NASDAQ:NTBL – Get Free Report) shares fell 3.1% on Monday . The stock traded as low as $1.23 and last traded at $1.26. 73,343 shares were traded during trading, a decline of 83% from the average session volume of 437,002 shares. The stock had previously closed at $1.30. Wall Street Analysts Forecast […]